                                                                                                                   
                                                   UNITED STATES                                                   
                                                                                                                   
                                                                                                                   
                                        SECURITIES AND EXCHANGE COMMISSION                                         
                                                                                                                   
                                                                                                                   
                                               WASHINGTON, DC 20549                                                
                                                                                                                   
                                                                                                                   
                                                     FORM 8-K                                                      
                                                                                                                   
                                                  CURRENT REPORT                                                   
                                                                                                                   
                                      Pursuant to Section 13 or 15(d) of The                                       
                                                                                                                   
                                          Securities Exchange Act of 1934                                          
                                                                                                                   
                                 Date of report (Date of earliest event reported):                                 
                                                                                                                   
                                                  August 19, 2021                                                  
                                                                                                                   
                                                 Johnson & Johnson                                                 
                                                                                                                   
                              (Exact name of registrant as specified in its charter)                               
                                                                                                  
  New Jersey                         1-3215                     22-1024240                        
  (State or Other Jurisdiction of    -Commission File Number    -IRS Employer Identification No.  
  Incorporation)                                                                                  
                                                                                                  
                           One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933                            
                                                                                                                   
                                     (Address of Principal Executive Offices)                                      
                                                                                                                   
                                                    (Zip Code)                                                     
                                                                                                                   
                                Registrant's telephone number, including area code:                                
                                                                                                                   
                                                   732- 524-0400                                                   
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation
of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Recommencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17

CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17

CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the
Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2
of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section
13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:
                                                                                                    
  Title of each class               Trading Symbol(s)    Name of each exchange on which registered  
  Common Stock, Par Value $1.00     JNJ                  New York Stock Exchange                    
  0.250% Notes Due January 2022     JNJ22                New York Stock Exchange                    
  0.650% Notes Due May 2024         JNJ24C               New York Stock Exchange                    
  5.50% Notes Due November 2024     JNJ24BP              New York Stock Exchange                    
  1.150% Notes Due November 2028    JNJ28                New York Stock Exchange                    
  1.650% Notes Due May 2035         JNJ35                New York Stock Exchange                    
                                                                                                    
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.

On August 19, 2021, the Board of Directors (the “Board”) of Johnson & Johnson (the “Company”) decided:

• Alex Gorsky, currently Chairman and Chief Executive Officer (“CEO”) of the Company, will relinquish the CEO
position, effective January 3, 2022, and will continue his service on the Board as Executive Chairman.

• Joaquin Duato will become CEO of the Company, effective January 3, 2022;

• Mr. Duato will be appointed a Director of the Board, effective January 3, 2022; and

A copy of the Company's press release, dated August 19, 2021, to announce these decisions is contained in Exhibit
99 to this Report.

Mr. Duato, age 59, is currently Vice Chairman of the Company's Executive Committee and provides strategic direction
for the Pharmaceutical and Consumer Health sectors and oversees the Global Supply Chain, Technology and Health &
Wellness teams. Mr. Duato originally joined the Company in 1989. In 2005, he was named President of Ortho Biotech,
LP, a subsidiary of the Company. In 2007, he was appointed Company Group Chairman for the Company's Ortho Clinical
Diagnostics business. Mr. Duato was appointed Company Group Chairman for the Company's pharmaceuticals business in
2009. In 2011, Mr. Duato was appointed Worldwide Chair of the Company’s pharmaceuticals business. Mr. Duato became
a Member of the Executive Committee in 2016 and was appointed as Vice Chairman of the Executive Committee in July
2018.

Mr. Duato a dual citizen of Spain and the United States, holds a Master of Business Administration from ESADE in
Barcelona, Spain, and a Master of International Management from Thunderbird School of Global Management at Arizona
State University in Phoenix, Arizona.

Employment arrangements in connection with the announced transitions are still to be finalized.
                                                                                                                   
  Item 9.01 Financial Statements and Exhibits                                                                      
                                                                                                                   
(d) Exhibits.
                                                                                                 
  Exhibit No.    Description of Exhibit                                                          
  99.1           Press Release datedAugust19, 2021                                               
 ─────────────────────────────────────────────────────────────────────────────────────────────── 
  104            The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.  
                                                                                                 
                                                                                                                   
                                                    SIGNATURES                                                     
                                                                                                                   
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
                                                                     
                              Johnson &         (Registrant)         
  Date:    August 20, 2021    Johnson    By:    /s/ Matthew Orlando  
 ─────────────────────────────────────────────────────────────────── 
                                                Matthew Orlando      
                                                Corporate Secretary  
                                                                     
